Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Suvorexant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06679062
What this trial is testing

Suvorexant for Treatment of AUD and PTSD

Who this might be right for
Alcohol Use Disorder (AUD)Post Traumatic Stress Disorder (PTSD)Insomnia
Pharmacotherapies for Alcohol and Substance Use Disorders Alliance 76
Testing effectiveness (Phase 2)Looking for participantsNCT06484075
What this trial is testing

Suvorexant for Alcohol Use Disorder (AUD): Neural Mechanisms

Who this might be right for
Healthy VolunteersAlcohol Use Disorder (AUD)
National Institute on Alcohol Abuse and Alcoholism (NIAAA) 180
Very early researchActive Not RecruitingNCT04273776
What this trial is testing

A Comparison of the Physiological and Behavioral Effects of Suvorexant and Zolpidem in Healthy Volunteers: A Randomized, Double-blind, Placebo Controlled Study

Who this might be right for
Performance Enhancing Product Use
Walter Reed Army Institute of Research (WRAIR) 90
Early research (Phase 1)Study completedNCT01293006
What this trial is testing

Effects of Suvorexant in Patients With Chronic Obstructive Pulmonary Disease (MK-4305-032)

Who this might be right for
Insomnia
Merck Sharp & Dohme LLC 25
Post-approval studies (Phase 4)UnknownNCT02669030
What this trial is testing

A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia

Who this might be right for
DepressionMajor Depressive DisorderMDD+1 more
Institute for Advanced Medical Research, Alpharetta, GA 74
Early research (Phase 1)Study completedNCT01043926
What this trial is testing

Pharmacokinetics of Suvorexant in Participants With Hepatic Insufficiency (MK-4305-017)

Who this might be right for
InsomniaHepatic Insufficiency
Merck Sharp & Dohme LLC 16
Post-approval studies (Phase 4)Study completedNCT03818581
What this trial is testing

Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusInsomniaSleep Disorder+1 more
Massachusetts General Hospital 108
Testing effectiveness (Phase 2)UnknownNCT03755310
What this trial is testing

Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant

Who this might be right for
Restless Legs Syndrome
Diego García-Borreguero, MD, PhD 43
Large-scale testing (Phase 3)Study completedNCT01097616
What this trial is testing

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)

Who this might be right for
Primary Insomnia
Merck Sharp & Dohme LLC 1,023
Post-approval studies (Phase 4)Study completedNCT02849184
What this trial is testing

To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia

Who this might be right for
HypertensionInsomnia
Jichi Medical University 82
Large-scale testing (Phase 3)Study completedNCT03412591
What this trial is testing

The Efficacy of Suvorexant in Treatment of Patients With Substance Use Disorder and Insomnia: A Pilot Open Trial

Who this might be right for
Sleep DisturbanceCravingCortisol; Hypersecretion
Milton S. Hershey Medical Center 28
Large-scale testing (Phase 3)Study completedNCT01097629
What this trial is testing

Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)

Who this might be right for
Primary Insomnia
Merck Sharp & Dohme LLC 1,020
Post-approval studies (Phase 4)Study completedNCT06584942
What this trial is testing

Evaluation of Suvorexant for Reduction of Brain Reactivity in Patients With Cannabis Use Disorder (Pilot Study)

Who this might be right for
Cue-reactivityCannabis Use DisorderFunctional MRI+1 more
Massachusetts General Hospital 20
Large-scale testing (Phase 3)Study completedNCT01021813
What this trial is testing

A Long Term Safety Study of Suvorexant in Participants With Primary Insomnia (MK-4305-009 AM3)

Who this might be right for
Insomnia
Merck Sharp & Dohme LLC 781
Testing effectiveness (Phase 2)Study completedNCT05546515
What this trial is testing

Suvorexant for Opioid/Stimulant Co-use

Who this might be right for
Opioid Use DisorderStimulant Use Disorder
Johns Hopkins University 20
Early research (Phase 1)Study completedNCT01300455
What this trial is testing

Effects of Suvorexant in Participants With Obstructive Sleep Apnea (MK-4305-036)

Who this might be right for
Sleep Apnea
Merck Sharp & Dohme LLC 26
Testing effectiveness (Phase 2)Study completedNCT02785406
What this trial is testing

Role of the Orexin Receptor System in Stress, Sleep and Cocaine Use

Who this might be right for
Cocaine Use DisorderAnxiety
The University of Texas Health Science Center, Houston 20
Post-approval studies (Phase 4)WithdrawnNCT03764683
What this trial is testing

Suvorexant (Belsomra) for the Treatment of Bipolar Depression With Insomnia

Who this might be right for
Bipolar DisorderInsomnia
Massachusetts General Hospital
Post-approval studies (Phase 4)UnknownNCT03768713
What this trial is testing

Impact of Suvorexant on Sympathetic Nerve Activity and Baroreflex Function in Chronic Insomnia

Who this might be right for
Chronic Insomnia
Montana State University 34
Very early researchLooking for participantsNCT06326684
What this trial is testing

Suvorexant and Alcohol

Who this might be right for
Alcohol Use Disorder
William Stoops 30
Next Page